Ontology highlight
ABSTRACT:
SUBMITTER: Hurwitz J
PROVIDER: S-EPMC10458257 | biostudies-literature | 2023 Jul
REPOSITORIES: biostudies-literature
Hurwitz Joshua J Haggstrom Lucy Roxana LR Lim Elgene E
Pharmaceutics 20230726 8
Antibody-drug conjugates (ADCs) have provided new therapeutic options and significant promise for patients with cancer, particularly where existing treatments are limited. Substantial effort in ADC development is underway globally, with 13 ADCs currently approved and many more in development. The therapeutic benefits of ADCs leverage the ability to selectively target cancer cells through antibody binding, resultant relative sparing of non-malignant tissues, and the targeted delivery of a cytotox ...[more]